AH
Amit Hazan Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Bioventus
BVS
$481M
| $7.19 | $2.50 |
65%
downside
| Neutral |
30 Nov ‘22
2 years ago |
|
2
The Beauty Health Co
SKIN
$260M
| $2.05 | $19 |
827%
upside
| Buy |
23 Nov ‘22
2 years ago |
|
3
Sotera Health
SHC
$4.44B
| $15.62 | $8 |
49%
downside
| Neutral |
23 Nov ‘22
2 years ago |
|
4
LivaNova
LIVN
$3.17B
| $57.97 | $63 |
9%
upside
| Buy |
23 Nov ‘22
2 years ago |
|
5
Becton Dickinson
BDX
$55.1B
| $192.39 | $272 |
41%
upside
| Buy |
23 Nov ‘22
2 years ago |
|
6
Bausch + Lomb
BLCO
$5.31B
| $15.01 | $17 |
13%
upside
| Neutral |
23 Nov ‘22
2 years ago |
|
7
Outset Medical
OM
$249M
| $14.01 | $435 |
3,005%
upside
| Buy |
9 Nov ‘22
2 years ago |
|
8
Procept Biorobotics
PRCT
$2.26B
| $40.68 | $44 |
8%
upside
| Neutral |
4 Nov ‘22
2 years ago |
|
9
Edwards Lifesciences
EW
$47.5B
| $80.94 | $73 |
10%
downside
| Neutral |
3 Nov ‘22
2 years ago |
|
10
Baxter International
BAX
$12.5B
| $24.42 | $53 |
117%
upside
| Sell |
3 Nov ‘22
2 years ago |
|
11
Enovis
ENOV
$1.84B
| $32.13 | $57 |
77%
upside
| Buy |
11 Oct ‘22
2 years ago |
|
12
Alphatec Holdings
ATEC
$2.43B
| $16.40 | $9.50 |
42%
downside
| Neutral |
8 Aug ‘22
3 years ago |
|
13
Abbott
ABT
$231B
| $132.94 | $104 |
22%
downside
| Sell |
25 Jul ‘22
3 years ago |
|
14
10x Genomics
TXG
$1.74B
| $13.96 | $60 |
330%
upside
| Neutral |
14 Jul ‘22
3 years ago |
|
15
Medtronic
MDT
$119B
| $92.90 | $115 |
24%
upside
| Neutral |
18 Jan ‘22
3 years ago |
|
16
Stryker
SYK
$150B
| $392.31 | $150 |
62%
downside
| Sell |
1 Apr ‘20
5 years ago |
|
17
Boston Scientific
BSX
$159B
| $107.22 | $46 |
57%
downside
| Neutral |
13 Feb ‘20
5 years ago |
|
18
Intuitive Surgical
ISRG
$167B
| $466.86 | $241.67 |
48%
downside
| Buy |
13 Feb ‘20
5 years ago |
|
19
Zimmer Biomet
ZBH
$20.9B
| $105.73 | $177 |
67%
upside
| Buy |
13 Feb ‘20
5 years ago |
|